CRISPR-based pharmacogenomic screening is used most often in ... new ways in which researchers might combat drug resistance and make cancer therapies more effective. Kampmann’s lab is now ...

If your immune system is working normally, it produces legions of T-cells that go around looking for abnormalities like cancer cells just ... cells are sent off to a CRISPR lab, where they get ...

Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice. The novel drug CT-179 was ...

T-cell therapies where immune cells are genetically engineered to attack specific tumors. In addition, some companies are using CRISPR for screening (which shouldn't be confused with genetic testing).

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Scientists have developed a new system using the CRISPR genome-editing system to attack ...

“CRISPR may be more convenient for gene editing than the prior gene editing tools used.” The study is not the first to use gene editing to interrupt the CCR5 gene in human hematopoietic ...

The team made significant strides in the fight against pediatric cancer by studying tumors ... culture systems for high-throughput drug screening and CRISPR-based functional genomics studies.

This study presents a useful finding that targeting amino acid metabolism can overcome Trastuzumab resistance in HER2+ breast cancer. The evidence supporting the claims of the authors is solid and the ...

The role of tumor suppressors in cancer drug resistance PET-scan of a metastatic melanoma patient who initially responded to therapy but eventually developed resistance. Most of the current targeted ...